HUM vs IMA
Humana Inc (HUM) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IMA currently screens at market cap $64.7M.
Not investment advice. Open the HUM and IMA stock pages for the full models.
Not investment advice.